Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 98, Issue 6, 2006, Pages 604-610

  Singh, Arya Dharamvir ^a   Amit, Saxena ^a   Kumar, Ojha Shreesh ^a   Rajan, Mittal ^a   Mukesh, Nandave ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CREATINE KINASE MB; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; MALONALDEHYDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HEMODYNAMICS; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID PEROXIDATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CREATINE KINASE; DIASTOLE; HEART RATE; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SULFONAMIDES; SURVIVAL ANALYSIS; SYSTOLE; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33646750164     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_405.x     Document Type: Article

References (35)

1. Andersson B. M. Lomsky F. Waagstein : The link between acute hemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. A study of diastolic function, heart rate and myocardial metabolism following intravenous metoprolol. Eur. Heart J. 1993, 14, 1375 1385.
2. Ceconi C. A. Cargnoni E. Pasini E. Condorelli S. Curello R. Ferrari : Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Amer. J. Physiol. 1991, 260, H1057 H1061.
3. Dinda A. K. S. Guleria S. Tiwari S. C. Dash A. Bagga : Diagnosis of glomerular hematuria by image cytometry of urinary red cells. Nephron 2001, 88, 93 99.
4. Ergul A. : Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy 2002, 22, 54 65.
5. Gao F. C. L. Yao E. Gao Q. Z. Mo W. L. Yan R. McLaughlin B. L. Lopez T. A. Christopher X. L. Ma : Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J. Pharmacol. Exp. Therap. 2002, 301, 543 550.
6. Gobel F. L. L. A. Nordstrom R. R. Nelson C. R. Jorgenson Y. Wang : The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 1978, 57, 549 556.
7. Grenadier E. S. Keider L. Kahana G. Alpan A. Marmur A. Palant : The roles of serum myoglobin, total CPK, and CK-MB isoenzyme in the acute phase of myocardial infarction. Amer. Heart J. 1983, 105, 408 416.
8. Grover G. J. P. G. Sleph M. Fox N. C. Trippodo : Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts. J. Pharmacol. Exp. Therap. 1992, 263, 1074 1082.
9. Grover G. J. S. Dzwonczyk C. S. Parham : The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc. Res. 1993, 27, 1613 1618.
10. Iimuro M. M. Kaneko Y. Matsumoto Y. Fujise T. Watanabe H. Hayashi : Effects of an endothelin receptor antagonist TAK-044 on myocardial energy metabolism in ischemia/reperfused rat hearts. J. Cardiovasc. Pharmacol. 2000, 35, 403 409.
11. Ishida K. K. Takeshige S. Minakami : Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem. Biophy. Res. Commun. 1990, 173, 496 500.
12. Jennings R. B. K. A. Reimer : The cell biology of acute myocardial ischemia. Ann. Rev. Med. 1991, 42, 225 246.
13. Kojima M. K. Kusumoto S. Fujiwara T. Watanabe M. Fujino : Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044. J. Cardiovasc. Pharmacol. 1995, 26, S365 S368.
14. Krause S. M. J. J. Lynch I. I. Stabilito R. F. Woltmann : Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischemic injury following acute coronary artery occlusion in the dog. Cardiovasc. Res. 1994, 28, 1672 1678.
15. Lamprecht W. F. Stan H. Weisser F. Heinz : Determination of creatine phosphate and adenosine triphosphate with creatine kinase. In : Methods of enzymatic analysis. Ed.: H. U. Bergmeyer. Academic Press, New York, 1974, pp. 1776 1780.
16. Lie J. T. P. C. Pairolero K. E. Holley J. L. Titus : Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. J. Thorac. Cardiovasc. Surg. 1975, 69, 599 605.
17. Lopez-Farre A. A. Riesco G. Espinosa E. Digiuni M. R. Cernadas V. Alvarez M. Monton F. Rivas M. J. Gallego J. Egido : Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993, 88, 1166 1171.
18. McMurdo L. C. Thiemermann J. R. Vane : The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischemia and reperfusion. Brit. J. Pharmacol. 1994, 112, 75 80.
19. McMurray J. J. S. G. Ray I. Abdullah H. J. Dargie J. J. Morton : Plasma endothelin in heart failure. Circulation 1992, 85, 1374 1379.
20. Ohkawa H. N. Ohishi K. Yagi : Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351 358.
21. Omland T. R. T. Lie A. Aakvaag T. Aarsland K. Dickstein : Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994, 89, 1573 1579.
22. Richard V. N. Kaeffer M. Hogie C. Tron T. Blanc C. Thuillez : Role of endogenous endothelin in myocardial and coronary endothelial injury after ischemia and reperfusion in rats: Studies with bosentan, a mixed ETA - ETB antagonist. Brit. J. Pharmacol. 1994, 113, 869 876.
23. Schnackenberg C. G. W. J. Welch C. S. Wilcox : Normalization of blood pressure and renal vascular resistance in SHR with a membrane- permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension 1998, 32, 59 64.
24. Temsah R. M. T. Netticadan N. S. Dhalla : Mechanisms of cellular alterations due to ischemia-reperfusion injury in the heart. In : Myocardial ischemia and preconditioning. Eds.: N. S. Dhalla N. Takeda M. Singh A. Lukas. Kluwer Academic Publishers, Boston, 2003, pp. 149 164.
25. Tiefenbacher C. P. J. Kapitza V. Dietz C. H. Lee F. Niroomand : Reduction of myocardial infarct size by fluvastatin. Amer. J. Physiol. Heart. Circ. Physiol. 2003, 285, H59 64.
26. Tomoda H. : Plasma endothelin-1 in acute myocardial infarction with heart failure. Amer. Heart J. 1993, 125, 667 672.
27. Tonnessen T. A. Giaid D. Saleh P. A. Naess M. Yanagisawa G. Christensen : Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ. Res. 1995, 76, 767 772.
28. Velasco C. E. E. K. Jackson J. A. Morrow J. V. Vitola T. Inagami M. B. Forman : Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischemia and reperfusion. Cardiovasc Res. 1993, 27, 121 128.
29. Wainwright C. L. C. McCabe K. A. Kane : Endothelin and the ischemic heart. Curr. Vasc. Pharmacol. 2005, 3, 333 341.
30. Wang Q. D. X. S. Li J. M. Lundberg J. Pernow : Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischemic and reperfusion injury in the pig. Cardiovasc. Res. 1995, 29, 805 812.
31. Watanabe T. N. Suzuki M. Shimamoto M. Fujino A. Imada : Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ. Res. 1991, 69, 370 377.
32. Werns S. W. J. C. Fantone A. Ventura B. R. Lucchesi : Myocardial glutathione depletion impairs recovery of isolated blood perfused hearts after global ischemia. J. Mol. Cell. Cardiol. 1992, 24, 1215 1220.
33. Yanagisawa M. H. Kurihara S. Kimura Y. Tomobe M. Kobayashi Y. Mitsui Y. Yazaki K. Goto T. Masaki : A novel potent vasoconstrictor produced by vascular endothelial cells. Nature 1988, 332, 411 415.
34. Yoshida M. H. Nonoguchi A. Owada S. Ishiyama Y. Maeda K. Ando H. Iwamoto T. Shiigai F. Marumo K. Tomita : Three cases of malignant hypertension: The roles of endothelin-1 and the renin-angiotensin-aldosterone system. Clin. Nephrol. 1994, 42, 295 299.
35. Zijlstra F. A. Patel M. Jones C. L. Grines S. Ellis E. Garcia L. Grinfeld R. J. Gibbons E. E. Ribeiro F. Ribichini C. Granger F. Akhras W. D. Weaver R. J. Simes : Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur. Heart J. 2002, 23, 550 557.